Tandem Diabetes Care (TNDM) Asset Utilization Ratio (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Asset Utilization Ratio came in at 1.01 in Q1 2026, down 2.9% YoY from 1.04 in Q1 2025, and down 12.61% on a QoQ basis from 1.16 in Q4 2025.
Tandem Diabetes Care (TNDM) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Asset Utilization Ratio data on file, last reported at 1.01 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 2.9% year-over-year to 1.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.01 (down 2.9% YoY) and the FY2025 annual result came in at 1.1, up 12.1% from the prior year.
- Asset Utilization Ratio slipped to 1.01 in Q1 2026, from 1.16 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.16 in Q4 2025 to a low of 0.75 in Q2 2022.
- A 5-year average of 0.9 and a median of 0.83 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 5.53% — and 2025, when it surged 31.49%.
- Tracing TNDM's Asset Utilization Ratio over 5 years: stood at 0.76 in 2022, then rose by 3.57% to 0.79 in 2023, then rose by 23.6% to 0.98 in 2024, then climbed by 18.35% to 1.16 in 2025, then slipped by 12.61% to 1.01 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.01 (Q1 2026), 1.16 (Q4 2025), and 1.15 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.56 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 0.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.90 |
| Mar 31, 2026 | 1.01 |
| Dec 31, 2025 | 1.16 |
| Sep 30, 2025 | 1.15 |
| Jun 30, 2025 | 1.11 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 0.98 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.85 |
| Mar 31, 2024 | 0.81 |
| Dec 31, 2023 | 0.79 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 0.76 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 0.75 |
| Mar 31, 2022 | 0.77 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 0.80 |